Printer Friendly

Zecotek Subsidiary Receives USD 2.5m Payment.

M2 PHARMA-December 29, 2014-Zecotek Subsidiary Receives USD 2.5m Payment

(C)2014 M2 COMMUNICATIONS

Canada-based photonics technology company Zecotek Photonics Inc.'s (TSX Venture: ZMS) (Frankfurt: W1I) (OTCPK: ZMSPF) Zecotek Imaging Systems Pte. Ltd. subsidiary has received a payment of USD 2.5m for new and previous orders of the company`s LFS crystals and crystal arrays, the company said on Monday.

According to the company, the total sum includes an initial payment of USD 500,000, as part of a long term plan to supply crystal arrays for use in new generation Time of Flight positron emission tomography scanners, and pre-clinical scanners for pharmaceutical drug development.

Zecotek said its patented LFS scintillation crystals are known for their high light yields and ultra-fast decay times which allow for faster and higher-resolution operation of medical and industrial imaging devices including PET medical scanners.

The company is a is engaged in developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Dec 29, 2014
Words:184
Previous Article:Xenex Germ-Zapping Robot Makes Operating Room Debut.
Next Article:Spectrum Pharmaceuticals submits new drug application for Captisol-Enabled Melphalan (CE-Melphalan) HCl.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters